Abstract Introduction/Objective Head and neck sarcomas are challenging to diagnose and treat. Sarcomas in the head and neck region cause significant morbidity and mortality due to the vital structures affected. The rare nature of head and neck sarcomas also creates challenges in studying these entities. Methods/Case Report We performed a retrospective review of 40 cases of head and neck sarcomas at our institution from January 2000 to December 2023. Cases of metastatic sarcoma to the head and neck region were excluded. Skin and thyroid primary cases were also excluded. Results (if a Case Study enter NA) The initial age of diagnosis ranged from 2 years to 86 years with an average age of 39.2 years old. Thirteen pediatric patients were identified with the most common diagnosis being embryonal rhabdomyosarcoma and the most common location being the pharynx. The most common diagnosis among adult patients was chondrosarcoma with the most common location being the sinuses. Most patients presented at stage T2N0M0 and had an average survival of 4.4 years. Pediatric patients had a slightly greater average survival of 8.4 years. Adult patients had an average survival of 2.1 years. Conclusion Overall, head and neck sarcomas show poor prognosis and arise more commonly in the pharynx in pediatric patients and the sinuses in adult patients.
Read full abstract